Tuesday, November 18, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home AI & Quantum Computing

IBM’s AI Billions Fail to Impress as Structural Challenges Persist

Felix Baarz by Felix Baarz
October 4, 2025
in AI & Quantum Computing, Dow Jones, Earnings, Tech & Software
0
IBM Stock
0
SHARES
11
VIEWS
Share on FacebookShare on Twitter

IBM’s latest quarterly results delivered an unwelcome surprise to investors, with shares declining 3% in after-hours trading despite the company reporting an impressive $3 billion AI project pipeline. The market’s reaction signals that even substantial artificial intelligence successes cannot mask the deeper structural issues facing the established technology giant.

Mixed Performance Across Business Segments

The company fell short of Wall Street expectations with total revenue of $14.97 billion, missing the $15.07 billion consensus estimate. This disappointing overall performance occurred even as IBM’s software division emerged as a standout performer, generating $6.52 billion in revenue—surpassing projections of $6.37 billion and registering substantial 10% growth.

Red Hat, IBM’s billion-dollar acquisition from 2019, continues to be the portfolio’s star component. The open-source platform accelerated its expansion pace from 7% in the previous quarter to an impressive 14%. CEO Arvind Krishna highlighted that approximately 80% of AI-derived revenue originates from consulting services, though this segment simultaneously reveals underlying weaknesses.

Consulting and Infrastructure Divisions Struggle

The consulting business disappointed with revenue of $5.15 billion, representing a 0.5% decline. Chief Financial Officer Jim Kavanaugh attributed these results to ongoing macroeconomic uncertainty causing clients to delay spending decisions.

Should investors sell immediately? Or is it worth buying IBM?

More dramatic challenges emerged in the infrastructure segment, where revenue dropped 7% to $3.04 billion, significantly below the anticipated $3.24 billion. This shortfall was primarily driven by a 19% collapse in mainframe sales—traditionally one of IBM’s most reliable profit generators.

Strategic Moves and Operational Strengths

IBM continues to advance its hybrid cloud strategy with the planned $6.4 billion acquisition of HashiCorp, scheduled for early 2025. This transaction, representing the company’s second-largest purchase after Red Hat, aims to significantly enhance IBM’s automation capabilities through integration of Terraform technology.

Despite revenue headwinds, IBM demonstrated operational strength with $6.59 billion in free cash flow generated during the first nine months of the year. The software division’s impressive 83% gross margin provides clear evidence of the company’s ongoing transformation toward higher-margin technology services.

Ad

IBM Stock: Buy or Sell?! New IBM Analysis from November 18 delivers the answer:

The latest IBM figures speak for themselves: Urgent action needed for IBM investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from November 18.

IBM: Buy or sell? Read more here...

Tags: IBM
Felix Baarz

Felix Baarz

My name is Felix Baarz, and I look back on over fifteen years of experience as a business journalist. I have always been fascinated by the mechanisms and dynamics of global financial markets as well as the complex economic and political interconnections that shape our world. With this passion, I have made a name for myself as an expert on international financial markets and dedicate myself with great commitment to making even the most complex topics understandable and accessible to my readers. My roots lie in Cologne, where I was born and raised. Early on, my curiosity about economic topics and international developments sparked my interest in journalism. After completing my studies, I began my career as a business editor at a respected German trade publication. Here I laid the foundation for my professional career, but my curiosity soon drew me out into the wider world. A turning point in my life was moving to New York, where I lived for six years and gained insight into leading media houses. In this vibrant metropolis, I was able to report firsthand from the heart of the global financial world. From daily developments on Wall Street to major economic policy decisions that make waves worldwide, I had the opportunity to write about central topics that move people and markets alike. This time shaped my perspective and sharpened my view of global interconnections.

Related Posts

Red Cat Stock
Analysis

Red Cat Holdings: Record Growth Meets Market Disappointment

November 18, 2025
Applovin Stock
Analysis

Major Investors Abandon Applovin Stock

November 18, 2025
Oramed Stock
Earnings

Oramed’s Corporate Defense: A Biotech’s Battle for Autonomy

November 18, 2025
Next Post
Salesforce Stock

Salesforce Faces Credibility Crisis as Hackers Target Client Data

Eli Lilly and Stock

Eli Lilly Shares Surge on Regulatory and Expansion News

Red Cat Holdings Stock

Military Drone Specialist Red Cat Soars on Bullish Analyst Outlook

Recommended

Diana Shipping Inc and Stone Shipping Forge Lucrative Charter Agreement

2 years ago
Mondelez Stock

Mondelez Shares Face Critical Test Amid Commodity Pressures

1 month ago
COST stock news

Analyst Kenneth Wong Bullish on Autodesk Raises Price Target to 315

2 years ago
US Century Bank Stock

Regional Lender US Century Bank Delivers Stellar Quarterly Performance

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

MKS Instruments Delivers Stellar Quarterly Performance

Annovis Bio Stock Surges on Promising Parkinson’s Trial Results

Kezar Life Sciences Initiates Major Overhaul Following Regulatory Setback

Platinum’s Bull Run Faces Critical Test

Skye Bioscience Shares Plunge as Investor Lawsuit Filed

Is the iShares MSCI ACWI ETF’s Record Run Nearing Its End?

Trending

Red Cat Stock
Analysis

Red Cat Holdings: Record Growth Meets Market Disappointment

by Felix Baarz
November 18, 2025
0

Red Cat Holdings presents investors with a complex puzzle: how can a company reporting explosive quarterly growth...

Applovin Stock

Major Investors Abandon Applovin Stock

November 18, 2025
Oramed Stock

Oramed’s Corporate Defense: A Biotech’s Battle for Autonomy

November 18, 2025
MKS Instruments Stock

MKS Instruments Delivers Stellar Quarterly Performance

November 18, 2025
Annovis Bio Stock

Annovis Bio Stock Surges on Promising Parkinson’s Trial Results

November 18, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Red Cat Holdings: Record Growth Meets Market Disappointment
  • Major Investors Abandon Applovin Stock
  • Oramed’s Corporate Defense: A Biotech’s Battle for Autonomy

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com